Dyne Therapeutics

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook

Current Job Openings

102 Biology

106 Data Sciences

110 CMC

121 Clinical Operations

122 Medical Affairs

123 Pharmacovigilance

124 Biometrics

125 Translational Biomarkers

126 Clinical Development

130 Regulatory

140 Program Management

207 Legal

301 Commercial